Dimethindene, phenylephrine
Sold as Vibrocil-s nasal, Vibrocil-s
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
Background
Registration
- Applicants
- 2
- Registrations
- 2
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Glaxosmithkline Consumer Healthcare SA (Pty) Ltd | Vibrocil-s nasal | gel | G0227 | Not determined | None |
| Haleon South Africa (Pty) Ltd | Vibrocil-s | solution | W0093 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Vibrocil-s nasal gel EACH 100 g GEL CONTAINS DIMETHINDENE MALEATE 0,025 g PHENYLEPHRINE 0,25 g | Gel | G0227G/16.1/227 | Registered | Not determined | None |
| Vibrocil-s solution EACH 100 ml SOLUTION CONTAINS: DIMETHINDENE MALEATE 25 mg, PHENYLEPHRINE 250 mg | Solution | W0093W/16.1/93 | Registered | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Phenylephrine
- when intended for injection
- except ophthalmic preparations containing 0,2 percent or less. (S0)
- except for oral dosage forms, nasal dosage forms, or ophthalmic dosage forms containing more than 0,2 percent (S1)
Consolidated Schedules 06 July 2026, lines 7545 to 7552
S2: Dimethindene
Consolidated Schedules 06 July 2026, line 1854
S1: Phenylephrine
- when intended for oral dosage forms, nasal dosage forms, or ophthalmic dosage forms containing more than 0,2 percent; (S1)
- except ophthalmic preparations containing 0,2 percent or less; (S0)
- except when intended for injection. (S4)
Consolidated Schedules 06 July 2026, lines 1007 to 1014
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.